New drug tested to clear remaining blockages after stroke surgery

NCT ID NCT04785066

Summary

This study tested whether adding the medication dornase alfa (Pulmozyme) after mechanical clot removal could help restore better blood flow to the brain in stroke patients. The trial involved 39 people who had an ischemic stroke, received clot-busting medication, and were eligible for mechanical clot removal surgery. Researchers gave dornase alfa intravenously during the procedure to see if it could clear small, hard-to-reach clots that sometimes remain after surgery.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hôpital Fondation Adolphe de Rothschild

    Paris, Paris, 75019, France

Conditions

Explore the condition pages connected to this study.